VALINK THERAPEUTICS
"VALINK THERAPEUTICS" is a figurative mark owned by Valink Therapeutics Inc., filed at the USPTO on August 27, 2026. It is under examination and covers classes 1, 5, 9, 41, 42 and 44.
- Status
- Under examination
- Since August 27, 2026
- Filed
- August 27, 2026
- Registered
- Not yet
- Priority date
- August 26, 2026
- Claimed from United Kingdom
- Application no.
- 50074964
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 6 classes
Who owns VALINK THERAPEUTICS
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Valink Therapeutics Inc.
Dover, United States
Representative
Matthew Homyk
Blank Rome LLP
What the mark covers
The products and services VALINK THERAPEUTICS is filed for, grouped by Nice class.
Chemicals for use in industry and science; Protein for industrial use; Proteins for use in manufacture; Biological preparations for use in industry and science; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Monoclonal antibodies for scientific purposes; Chemical preparations for use in industry; Chemicals for use in biotechnological product development
Chemical preparations for pharmaceutical or medical purposes, namely, for use in the production of drugs; Pharmaceutical products for the prevention and treatment of cancer; Biological preparations for the treatment of cancer; Anti-cancer preparations; Chemotherapeutics; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for the treatment and prevention of cancer; Antibodies for medical purposes; Antibodies for veterinary purposes
Laboratory chemical reactors; Flow meters; Downloadable software for conducting research in chemical engineering; Downloadable software for conducting research in biochemistry; Downloadable software for conducting research in biochemical engineering; Computer software, recorded, for biochemistry to identify biological characteristics; Computer software, recorded, for chemical engineering to identify biological characteristics; Computer software, recorded, for biochemical engineering to identify biological characteristics; Laboratory equipment and supplies, namely, incubators; Computer programs, recorded, for testing chemicals in biochemistry; Computer programs, recorded, for testing chemicals in chemical engineering; Computer programs, recorded, for testing chemicals in biochemical engineering; Computer programs, downloadable, for performing biochemical engineering; Computer programs, downloadable, for performing chemical engineering; Computer programs, downloadable, for performing biochemistry
Publishing of electronic publications; Publishing and issuing of scientific papers in the field of biochemistry; Publishing and issuing of scientific papers in the field of chemical engineering; Publishing and issuing of scientific papers in the field of biochemical engineering; Publishing and issuing of scientific papers in the field of pharmaceuticals; Publishing and issuing of scientific papers in the field of cancer; Publishing and issuing of scientific papers in the field of medicine; Book publishing; Magazine publishing
Scientific and technological services, namely, research and design in the field of pharmaceutical, biomedical, and chemical sciences; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Research and development of pharmaceutical preparations for treating malignant tumours; Research and development in the pharmaceutical and biotechnology fields; Research and development services of new pharmaceutical products; Research and development of new products in the field of pharmaceuticals; Research and development in the field of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical products; Testing of pharmaceuticals; Biotechnology research; Biological research; Clinical research in the field of radiology and chemotherapy and medical research; Research and development in the field of vaccines and medicines; Scientific research for medical purposes in the field of cancerous diseases; Research and development services in the field of antibodies; Research and development in the field of biotechnology; Biochemical research; Biochemical research and development; Engineering services in the field of biochemical engineering; Veterinary research laboratory services; Medical research laboratory services; Providing scientific research information in the field of biochemistry and biotechnology; Pharmaceutical research services; Consulting services in the field of pharmaceutical research; Scientific research consulting in the field of biotechnology; Scientific research consulting in the field of therapeutics
Medical services; Pharmaceutical advice; Medical and pharmaceutical consultation; Medical analysis services for the diagnosis of cancer
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About VALINK THERAPEUTICS
Who owns the trademark "VALINK THERAPEUTICS"?
The USPTO trademark "VALINK THERAPEUTICS" (application 50074964) is owned by Valink Therapeutics Inc.
What is the status of "VALINK THERAPEUTICS"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull VALINK THERAPEUTICS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a04882-392d-72d7-9522-b0d168ad5cf2
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a04882-392d-72d7-9522-b0d168ad5cf2",
"object": "trademark",
"mark_text": "VALINK THERAPEUTICS",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50074964",
"filing_date": "2026-08-27",
"nice_classes": [
1,
5,
9,
41,
42,
44
],
"owners": [
{
"name": "Valink Therapeutics Inc.",
"entity_id": "ent_019ebb7e-9112-766d-ab2e-e6e6136db2e2"
}
]
}